Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00755924 · ClinicalTrials.gov registry record · Phase 1
Prospective Randomized Clinical Trial Evaluating the Impact of Vinegar on High Density Lipoprotein
A Phase 1 study, sponsored by HealthPartners Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 114
- Enrollment target
NCT00755924 is a Phase 1 study that has completed, run by HealthPartners Institute. The registered enrollment target is 114 participants.
The verdict
NCT00755924, a Phase 1 study, has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 114 participants
- Enrollment target
Study Summary
This is a double-blinded randomized placebo controlled prospective clinical trial evaluating the impact of apple cider vinegar on serum HDL. 112 participants will be randomized to consume either 2 tablespoons of vinegar daily or a placebo containing a 2% balsamic vinegar solution in water. Baseline, two month and 4 month blood samples will be obtained for fasting lipids. The primary endpoint is met if HDL levels increase in the treatment arm versus baseline after 2 month intervention.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Vinegar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2008-06 |
| Est. Completion | 2010-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00755924
The ClinicalTrials.gov registry entry for NCT00755924 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00755924 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00755924 about?
NCT00755924 is a clinical study titled "Prospective Randomized Clinical Trial Evaluating the Impact of Vinegar on High Density Lipoprotein". This is a double-blinded randomized placebo controlled prospective clinical trial evaluating the impact of apple cider vinegar on serum HDL. 112 participants will be randomized to consume either 2 tablespoons of vinegar daily or a placebo containing a 2% balsamic vinegar solution in water. Baseline,...
What is the current status of trial NCT00755924?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 114 participants. The study started on 2008-06. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00755924?
The interventions under investigation include: Placebo (OTHER), Vinegar (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00755924?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.